Supplementary Figure S1 from Combination AURKA and WEE1 Inhibition Exhibits Efficacy in EGFR or Pan-ERBB Inhibitor–Resistant Head and Neck Squamous Cell Carcinoma
Year: 2026
Type: supplementary-materials
Abstract: Characterization of erlotinib-resistant (ErlR) and afatinib-resistant (AfaR) HNSCC cell models.
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7202398254
Cites:
Cited by:
Related to: